Stanford Health Care CEO to become leader of United Health Group; New drug available to fight C. diff;

News From Around the Web

>  Amir Dan Rubin, CEO of Stanford Health Care in California, will leave the position at the end of the year, to lead UnitedHealth Group, the San Francisco Business Times reports. Article

> Researchers at the Stanford University School of Medicine have developed a new drug that is not an antibiotic to fight the deadly superbug, Clostridium difficile. Announcement

> Johns Hopkins researchers find that poor women with recent pregnancy complications use the emergency room at higher rates after delivery and may not receive the postpartum care and follow-up care necessary to prevent further health problems. The study is published in the September issue of Journal of Women's Health. Study abstract

Health Finance News

> A federal judge has thrown out a facet of the Centers for Medicare & Medicaid Services'  proposed two-midnight rule, which may delay implementation of a planned payment cut. Article

Health Payer News

> During this week's Senate committee hearing on the two pending health insurer mergers, the CEOs of Aetna and Anthem, as expected, explained why they thought the deals' benefits outweigh any anticompetitive concerns. Article

And Finally… The De-arted. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.